Amidines and Guanidines in Natural Products and Medicines

Superbases for Organic Synthesis: Guanidines, Amidines, Phosphazenes and Related Organocatalysts

Volumn , Issue , 2009, Pages 295-313

  Kumamoto, Takuya ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Amidines and guanidines in natural products and medicines; Medicinal amidine and guanidine derivatives; Natural amidine derivatives; Natural amidines from microorganisms and fungi; Natural guanidine derivatives; Natural guanidines from marine invertebrates; Natural guanidines from microorganisms; NOS inhibitors; Pentamidine

Indexed keywords

EID: 79955624369     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470740859.ch10     Document Type: Chapter

References (108)

1. Berlinck, R.G.S. (1995) Some Aspects of Guanidine Secondary Metabolites. Fortschritte der Chemie Organischer Naturstoffe, 66, 119-295.
2. Berlinck, R.G.S. (1996) Natural guanidine derivatives. Natural Product Reports, 13, 377-409.
3. Berlinck, R.G.S. (1999) Natural guanidine derivatives. Natural Product Reports, 16, 339-365.
4. Berlinck, R.G.S. (2002) Natural guanidine derivatives. Natural Product Reports, 19, 617-649.
5. Berlinck, R.G.S. and Kossuga, M.H. (2005) Natural guanidine derivatives. Natural Product Reports, 22, 516-550.
6. Kobayashi, J. and Ishibashi, M. (1992) Marine Alkaloids II, in The Alkaloids (eds A. Brossi and G.A. Cordell), 41, 41-124.
7. Kobayashi, J. and Ishibashi, M. (1999) Marine natural products and marine chemical ecology, in Comprehensive Natural Products Chemistry (eds D. Barton and K. Nakanishi), 8, 415-649.
8. Fattorusso E. and Taglialatela-Scafati O. (eds) (2007) Modern Alkaloids, Wiley-VCH Verlag GmbH, Weinheim.
9. Greenhill, J.V. and Lue, P. (1993) Amidines and guanidines in medicinal chemistry. Progress in Medicinal Chemistry, 30, 203-326.
10. Nakamura, S. and Umezawa, H. (1966) The structure of bottromycin A2, a new component of bottromycins. Chemical & Pharmaceutical Bulletin, 14, 981-986.
11. Schipper, D. (1983) The revised structure of bottromycin A2. The Journal of Antibiotics, 36, 1076-1077.
12. Kaneda, M. (2002) Studies on bottromycins. II. Structure elucidation of bottromycins B2 and C2. The Journal of Antibiotics, 55, 924-928.
13. Nakamura, H., Koyama, G., Iitaka, Y. et al. (1974) Structure of coformycin, an unusual nucleoside of microbial origin. Journal of the American Chemical Society, 96, 4327-4328.
14. Ohno, M., Yagisawa, N., Shibahara, S. et al. (1974) Synthesis of coformycin. Journal of the American Chemical Society, 96, 4326-4327.
15. Bartsch, A., Bross, M., Spiteller, P. et al. (2005) Birnbaumin A and B: two unusual 1- hydroxyindole pigments from the 'flower pot parasol' Leucocoprinus birnbaumii. Angewandte Chemie - International Edition, 44, 2597-2599.
16. Bullough, D.A., Jackson, C.G., Henderson, P.J.F. et al. (1982) The amino acid sequence of efrapeptin D. Biochemistry International, 4, 543-549.
17. Gupta, S., Krasnoff, S.B., Roberts, D.W. et al. (1991) Structures of the efrapeptins: Potent inhibitors of mitochondrial ATPase from the fungus Tolypocladium niveum. Journal of the American Chemical Society, 113, 707-709.
18. Fredenhagen, A., Molleyres, L., Böhlendorf, B. and Laue, G. (2006) Structure determination of neoefrapeptins A to N: Peptides with insecticidal activity produced by the fungus Geotrichum candidum. The Journal of Antibiotics, 59, 267-280.
19. Aoyama, T., Kojima, F., Imada, C. et al. (1995) Pyrostatins A and B, new inhibitors of N-acetylb-D-glucosaminidase, produced by Streptomyces sp. SA-3501. Journal of Enzyme Inhibition and Medicinal Chemistry, 8, 223-232.
20. Imada, C. (2005) Enzyme inhibitors and other bioactive compounds from marine actinomycetes. Antonie van Leeuwenhoek, 87, 59-63.
21. Castellanos, L., Duque, C., Zea, S. et al. (2006) Isolation and synthesis of (-)-(5S)-2-imino-1- methylpyrrolidine-5-carboxylic acid from Cliona tenuis: Structure revision of pyrostatins. Organic Letters, 8, 4967-4970.
22. Inbar, L. and Lapidot, A. (1988) The structure and biosynthesis of new tetrahydropyrimidine derivatives in actinomycin D producer Streptomyces parvulus. Use of 13C- and 15N- labeled L-glutamate and 13C and 15N NMR spectroscopy. The Journal of Biological Chemistry, 263, 16014-16022.
23. Inbar, L., Frolow, F. and Lapidot, A. (1993) The conformation of new tetrahydropyrimidine derivatives in solution and in the crystal. European Journal of Biochemistry, 214, 897-906.
24. Galinski, E.A., Pfeiffer, H.P. and Truper, H.G. (1985) 1,4,5,6-Tetrahydro-2-methyl-4-pyrimidinecarboxylic acid. A novel cyclic amino acid from halophilic phototrophic bacteria of the genus Ectothiorhodospira. European Journal of Biochemistry, 149, 135-139.
25. Peck, R.L., Shafer, H.M., Wolf, F.J. and Peck, H.M. (1957) b-(5-Imino-2-pyrrolidinylcarbonylamino) propamidine, U.S. Pat. 2804463.
26. Furusawa, E., Cutting, W., Buckley, P. and Furusawa, S. (1964) Complete cure of DNA virus infection in cultured cells by drug combinations. Proceedings of the Society for Experimental Biology and Medicine, 116, 938-944.
27. Green, B.G., Chabin, R. and Grant, S.K. (1996) The natural product noformycin is an inhibitor of inducible-nitric oxide synthase. Biochemical and Biophysical Research Communications, 225, 621-626.
28. Mitchell, R.E. and Teh, K.L. (2005) Antibacterial iminopyrrolidines from Burkholderia plantarii, a bacterial pathogen of rice. Organic and Biomolecular Chemistry, 3, 3540-3543.
29. Carle, J.S. and Christophersen, C. (1979) Bromo-substituted physostigmine alkaloids from a marine bryozoa Flustra foliacea. Journal of the American Chemical Society, 101, 4012-4013.
30. Carle, J.S. and Christophersen, C. (1981) Marine alkaloids. 3. Bromo-substituted alkaloids from the marine bryozoan Flustra foliacea, flustramine Cand flustraminolAand B. The Journal of Organic Chemistry, 46, 3440-3443.
31. Peters, L., Konig, G.M., Wright, A.D. et al. (2003) Secondary metabolites of Flustra foliacea and their influence on bacteria. Applied and Environmental Microbiology, 69, 3469-3475.
32. Peters, L., Konig, G.M., Terlau, H. and Wright, A.D. (2002) Four new bromotryptamine derivatives from the marine bryozoan Flustra foliacea. Journal of Natural Products, 65, 1633-1637.
33. Kawasaki, T., Terashima, R., Sakaguchi, K. et al. (1996) A short route to 'reverse-prenylated' pyrrolo[2,3-b]indoles via tandem olefination and Claisen rearrangement of 2-(3,3-dimethylallyloxy) indol-3-ones: First total synthesis of flustramine C. Tetrahedron Letters, 37, 7525-7528.
34. Fuchs, J.R. and Funk, R.L. (2005) Indol-2-one intermediates: mechanistic evidence and synthetic utility. Total syntheses of (±)-flustramines A and C. Organic Letters, 7, 677-680.
35. Lindel, T., Brauchle, L., Golz, G. and Bohrer, P. (2007) Total synthesis of flustramine C via dimethylallyl rearrangement. Organic Letters, 9, 283-286.
36. Verbitski, S.M., Mayne, C.L., Davis, R.A. et al. (2002) Isolation, structure determination, and biological activity of a novel alkaloid, perophoramidine, from the Philippine ascidian Perphore namei. The Journal of Organic Chemistry, 67, 7124-7126;
37. Fuchs, J.R. and Funk, R.L. (2004) Total synthesis of (±)-perophoramidine. Journal of the American Chemical Society, 126, 5068-5069.
38. Solís, P.N., Ravelo, A.G., Palenzuela, J.A. et al. (1997) Quinoline alkaloids from Psychotria glomerulata. Phytochemistry, 44, 963-969.
39. Verotta, L., Pilati, T., Tato, M. et al. (1998) Pyrrolidinoindoline alkaloids from Psychotria colorata. Journal of Natural Products, 61, 392-396.
40. Harada, K. (2004) Production of secondary metabolites by freshwater cyanobacteria. Chemical & Pharmaceutical Bulletin, 52, 889-899.
41. Waksman, S.A. (1951) Streptomycin, isolation, properties, and utilization. Journal of The History of Medicine and Allied Sciences, 6, 318-347.
42. Hisamoto, M., Inaoka, Y., Sakaida, Y. et al. (1998) A-53930A and B, novel N-type Ca2{thorn} channel blockers. The Journal of Antibiotics, 51, 607-617.
43. Kim, B.T., Lee, J.Y., Lee, Y.Y. et al. (1994) N-Methylstreptothricin D- a new streptothricingroup antibiotic from a Streptomyces spp. The Journal of Antibiotics, 47, 1333-1336.
44. Kajimura, Y. and Kaneda, M. (1996) Fusaricidin A, a new depsipeptide antibiotic produced by Bacillus polymyxa KT-8: Taxonomy, fermentation, isolation, structure elucidation and biological activity. The Journal of Antibiotics, 49, 129-135.
45. Kajimura, Y. and Kaneda, M. (1997) Fusaricidins B, C and D, new depsipeptide antibiotics produced by Bacillus polymyxa KT-8: Isolation, structure elucidation and biological activity. The Journal of Antibiotics, 50, 220-228.
46. Chandra, A. and Nair, M.G. (1995) Azalomycin F complex from Streptomyces hygroscopicus, MSU/MN-4-75B. The Journal of Antibiotics, 48, 896-898.
47. Black, H.R., Griffith, R.S. and Brickler, J.F. (1963) Preliminary laboratory studies with capreomycin. Antimicrobial Agents and Chemotherapy, 161, 522-529.
48. Nagata, A., Ando, T., Izumi, R. et al. (1968) Studies on tuberactinomycin (tuberactin), a new antibiotic. I. Taxonomy of producing strain, isolation and characterization. The Journal of Antibiotics, 21, 681-687.
49. Nakao, Y., Fujita, M., Warabi, K. et al. (2000) Miraziridine A, a novel cysteine protease inhibitor from the marine sponge Theonella aff. mirabilis. Journal of the American Chemical Society, 122, 10462-10463.
50. Llewellyn, L.E. (2006) Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Natural Product Reports, 23, 200-222.
51. Goto, T., Inoue, S. and Sugiura, S. (1968) Cypridina bioluminescence IV. Synthesis and chemiluminescence of 3,7-dihydroimidazo[1,2-a]pyrazin-3-one and its 2-methyl derivative. Tetrahedron Letters, 3873-3876.
52. Omura, S., Arai, N., Yamaguchi, Y. et al. (2000) Argifin, a new chitinase inhibitor, produced by Gliocladium sp. FTD-0668. I. Taxonomy, fermentation, and biological activities. The Journal of Antibiotics, 53, 603-608.
53. Arai, N., Shiomi, K., Iwai, Y. and Omura, S. (2000) Argifin, a newchitinase inhibitor, produced by Gliocladium sp. FTD-0668. II. Isolation, physico-chemical properties, and structure elucidation. The Journal of Antibiotics, 53, 609-614.
54. Shiomi, K., Arai, N., Iwai, Y. et al. (2000) Structure of argifin, a new chitinase inhibitor produced by Gliocladium sp. Tetrahedron Letters, 41, 2141-2143.
55. Dixon, M.J., Andersen, O.A., van Aalten, D.M. and Eggleston, I.M. (2005) An efficient synthesis of argifin: a natural product chitinase inhibitor with chemotherapeutic potential. Bioorganic & Medicinal Chemistry Letters, 15, 4717-4721.
56. Gouda, H., Yanai, Y., Sugawara, A. et al. (2008) Computational analysis of the binding affinities of the natural-product cyclopentapeptides argifin and argadin to chitinase B from Serratia marcescens. Bioorganic and Medicinal Chemistry, 16, 3565-3579.
57. Shoji, J., Hinoo, H., Katayama, T. et al. (1992) Isolation and characterization of new peptide antibiotics, plusbacins A1-A4 and B1-B4. The Journal of Antibiotics, 45, 817-823.
58. Shoji, J., Hinoo, H., Katayama, T. et al. (1992) Structures of new peptide antibiotics, plusbacins A1-A4 and B1-B4. The Journal of Antibiotics, 45, 824-831.
59. Maki, H., Miura, K. and Yamano, Y. (2001) Katanosin B and plusbacin A3, inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 45, 1823-1827.
60. Wohlrab, A., Lamer, R. and VanNieuwenhze, M.S. (2007) Total synthesis of plusbacin A3: a depsipeptide antibiotic active against vancomycin-resistant bacteria. Journal of the American Chemical Society, 129, 4175-4177.
61. Omura, S., Tomoda, H., Abe, A. et al. (2007) Guadinomine antibiotics manufacture with Streptomyces, WO 2007/102229.
62. Tsuchiya, S., Sunazuka, T., Hirose, T. et al. (2006) Asymmetric total synthesis of ({thorn})-K01-0509 B: determination of absolute configuration. Organic Letters, 8, 5577-5580.
63. Kinnel, R.B., Gehrken, H.-P. and Scheuer, P.J. (1993) Palau'amine: a cytotoxic and immunosuppressive hexacyclic bisguanidine antibiotic from the sponge Stylotella agminata. Journal of the American Chemical Society, 115, 3376-3377.
64. Kinnel, R.B., Gehrken, H.-P., Swali, R. et al. (1998) Palau'amine and its congeners: A family of bioactive bisguanidines from the marine sponge Stylotella aurantium. The Journal of Organic Chemistry, 63, 3281-3286.
65. Lanman, B.A., Overman, L.E., Paulini, R. and White, N.S. (2007) On the structure of palau'amine: Evidence for the revised relative configuration from chemical synthesis. Journal of the American Chemical Society, 129, 12896-12900.
66. Grube, A. and Köck, M. (2007) Structural assignment of tetrabromostyloguanidine: does the relative configuration of the palau'amines need revision? Angewandte Chemie - International Edition, 46, 2320-2324.
67. Buchanan, M.S., Carroll, A.R., Addepalli, R. et al. (2007) Natural products, stylissadines Aand B, specific antagonists of the P2X7 receptor, an important inflammatory target. The Journal of Organic Chemistry, 72, 2309-2317.
68. Kobayashi, H., Kitamura, K., Nagai, K. et al. (2007) Carteramine A, an inhibitor of neutrophil chemotaxis, from the marine sponge Stylissa carteri. Tetrahedron Letters, 48, 2127-2129.
69. Köck, M., Achim, G., Seipe, I.B. and Baran, P.S. (2007) The pursuit of palau'amine. Angewandte Chemie - International Edition, 46, 6586-6594.
70. Berlinck, R.G.S., Braekman, J.C., Daloze, D. et al. (1990) Two new guanidine alkaloids from the mediterranean sponge Crambe crambe. Tetrahedron Letters, 31, 6531-6534.
71. Jares-Erijman, E.A., Ingrum, A.A., Sun, F. and Rinehart, K.L. (1993) On the structures of crambescins B and C1. Journal of Natural Products, 56, 2186-2188.
72. Gerlinck, R.G.S., Braekman, J.C., Daloze, D. et al. (1992) Crambines C1 and C2: Two further ichthyotoxic guanidine alkaloids from the sponge Crambe crambe. Journal of Natural Products, 55, 528-532.
73. Snider, B.B. and Shi, Z. (1992) Biomimetic synthesis of the bicyclic guanidine moieties of crambines A and B. The Journal of Organic Chemistry, 57, 2526-2528.
74. Harbour, G.C., Tymiak, A.A., Rinehart, K.L. et al. (1981) Ptilocaulin and isoptilocaulin, antimicrobial and cytotoxic cyclic guanidines from the Caribbean sponge Ptilocaulis aff. P. spiculifer (Lamarck, 1814). Journal of the American Chemical Society, 103, 5604-5606.
75. Kashman, Y., Hirsh, S., McConnell, O.J. et al. (1989) Ptilomycalin A: a novel polycyclic guanidine alkaloid of marine origin. Journal of the American Chemical Society, 111, 8925-8926.
76. Palagiano, E., De Marino, S., Minale, L. et al. (1995) Pitlomycalin A, crambescidin 800 and related new highly cytotoxic guanidine alkaloids from the starfishes Fromia monilis and Celerina heffernani. Tetrahedron, 51, 3675-3682.
77. Patil, A.D., Kumar, N.V., Kokke, W.C. et al. (1995) Novel alkaloids from the sponge Batzella sp.: Inhibitors of HIV gp120-human CD4 binding. The Journal of Organic Chemistry, 60, 1182-1188.
78. Patil, A.D., Freyer, A.J., Taylor, P.B. et al. (1997) Batzelladines F-I, novel alkaloids from the sponge Batzella sp.: Inducers of p56lck-CD4 dissociation. The Journal of Organic Chemistry, 62, 1814-1819.
79. Snider, B.B. and Chen, J. (1996) Synthesis of the tricyclic portions of batzelladines A, B and D. Revision of the stereochemistry of batzelladines A and D. Tetrahedron Letters, 37, 6977-6980.
80. Cohen, F. and Overman, L.E. (2006) Enantioselective total synthesis of batzelladine F and definition of its structure. Journal of the American Chemical Society, 128, 2604-2608.
81. Bensemhoun, J., Bombarda, I., Aknin, M. et al. (2007) Ptilomycalin D, a polycyclic guanidine alkaloid from the marine sponge Monanchora dianchora. Journal of Natural Products, 70, 2033-2035.
82. Gallimore, W.A., Kelly, M. and Scheuer, P.J. (2005) Alkaloids from the sponge Monanchora unguifera. Journal of Natural Products, 68, 1420-1423.
83. Hua, H., Peng, J., Dunbar, D.C. et al. (2007) Batzelladine alkaloids from the Caribbean sponge Monanchora unguifera and the significant activities against HIV-1 and AIDS opportunistic infectious pathogens. Tetrahedron, 63, 11179-11188.
84. Arnold, M.A., Day, K.A., Duron, S.G. and Gin, D.Y. (2006) Total synthesis of ({thorn})-batzelladine A and (+)-batzelladine D via [4{thorn}2]-annulation of vinyl carbodiimides with N-alkyl imines. Journal of the American Chemical Society, 128, 13255-13260.
85. Shimokawa, J., Ishiwata, T., Shirai, K. et al. (2005) Total synthesis of ({thorn})-batzelladine A and (+)-batzelladine D, and identification of their target protein. Chemistry - A European Journal, 11, 6878-6888.
86. Witherup, K.M., Ransom, R.W., Graham, A.C. et al. (1995) Martinelline and martinellic acid, novel G-protein linked receptor antagonists from the tropical plant Martinella iquitosensis (Bignoniaceae). Journal of the American Chemical Society, 117, 6682-6685.
87. Ma, D., Xia, C., Jiang, J. and Zhang, J. (2001) First total synthesis of martinellic acid, a naturally occurring bradykinin receptor antagonist. Organic Letters, 3, 2189-2191.
88. Ma, D., Xia, C., Jiang, J. et al. (2003) Aromatic nucleophilic substitution or CuI-catalyzed coupling route to martinellic acid. The Journal of Organic Chemistry, 68, 442-451.
89. Ikeda, S., Shibuya, M. and Iwabuchi, Y. (2007) Asymmetric total synthesis of martinelline and martinellic acid. Chemical Communications, 504-506.
90. Watanabe, C.K. (1918) Studies in the metabolism changes induced by administration of guanidine bases. I. Influence of injected guanidine hydrochloride upon blood sugar content. The Journal of Biological Chemistry, 33, 253-265.
91. Luft, D., Schmülling, R.M. and Eggstein, M. (1978) Lactic acidosis in biguanide-treated diabetics. Diabetologia, 14, 75-87.
92. Witters, L.A. (2001) The blooming of the French lilac. The Journal of Clinical Investigation, 108, 1105-1107.
93. Black, J.W., Duncan, W.A.M., Durant, C.J. et al. (1972) Definition and antagonism of histamine H2-receptors. Nature, 236, 385-390.
94. Durant, G.J., Emmett, J.C., Ganellin, C.R. et al. (1977) Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine. Journal of Medicinal Chemistry, 20, 901-906.
95. Rodloff, A.C., Goldstein, E.J. and Torres, A. (2006) Two decades of imipenem therapy. The Journal of Antimicrobial Chemotherapy, 58, 916-929.
96. Leanza, W.J., Wildonger, K.J., Miller, T.W. and Christensen, B.G. (1979) N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal b-lactam antibiotics. Journal of Medicinal Chemistry, 22, 1435-1436.
97. Olken, N.M. and Marletta, M.A. (1993) NG-Methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry, 32, 9677-9685.
98. Feldman, P.L., Griffith, O.W., Hong, H. and Stuehr, D.J. (1993) Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPHdependent hydroxylation. Journal of Medicinal Chemistry, 36, 491-496.
99. Furfine, E.S., Harmon, M.F., Paith, J.E. and Garvey, E.P. (1993) Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry, 32, 8512-8517.
100. Rees, D.D., Palmer, R.M.J., Schulz, R. et al. (1990) Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 101, 746-752.
101. Moore, W.M., Webber, R.K., Jerome, G.M. et al. (1994) L-N6-(1-Iminoethyl)lysine:Aselective inhibitor of inducible nitric oxide synthase. Journal of Medicinal Chemistry, 37, 3886-3888.
102. Alderton, W.K., Angell, A.D.R., Craig, C. et al. (2005) GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 145, 301-312.
103. Sands, M., Kron, M.A. and Brown, R.B. (1985) Pentamidine: a review. Reviews of Infectious Diseases, 7, 625-634.
104. Goa, K.L. and Campoli-Richards, D.M. (1987) Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs, 33, 242-258.
105. Fox, K.R., Sansom, C.E. and Stevens, M.F.G. (1990) Footprinting studies on the sequenceselective binding of pentamidine to DNA. FEBS Letters, 266, 150-154.
106. Sun, T. and Zhang, Y. (2008) Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation. Nucleic Acids Research, 36, 1654-1664.
107. Makulu, D.R. and Waalkes, T.P. (1975) Interaction between aromatic diamidines and nucleic acids: possible implications for chemotherapy. Journal of the National Cancer Institute, 54, 305-309.
108. Chen, D., Marsh, R. and Aberg, J.A. (2007) Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individuals. Expert Review of Anti-Infective Therapy, 5, 921-928.